Exercise prescription in cardiac patients treated with metoprolol – should the time of day for stress tests and training coincide?

Abstract

Get full access to this article

View all access options for this article.

References

Dufour Doiron

Prud’homme

Boulay

. Time-of-day variation in cardiovascular response to maximal exercise testing in coronary heart disease patients taking a beta-blocker. Appl Physiol Nutr Metab 2007; 32: 664–669.

Franklin

Gordon

Timmis

. Diurnal variation of ischemic response to exercise in patients receiving a once-daily dose of beta-blockers. Implications for exercise testing and prescription of exercise and training heart rates. Chest 1996; 109: 253–257.

Piepoli

Hoes

Agewall

et al.

2016 European Guidelines on cardiovascular disease prevention in clinical practice: Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol 2016; 23: NP1–NP96.

Zanettini

Centeleghe

Ratti

et al.

Training prescription in patients on beta-blockers: Percentage peak exercise methods or self-regulation?

Eur J Prev Cardiol 2012; 19: 205–212.

Kraal

Sartor

Papini

et al.

Energy expenditure estimation in beta-blocker-medicated cardiac patients by combining heart rate and body movement data. Eur J Prev Cardiol 2016; 23: 1734–1742.

Rau

Heide

Bergmann

et al.

Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment. Pharmacogenetics 2002; 12: 465–472.

Poolsup

Li Wan Po

Knight

. Pharmacogenetics and psychopharmacotherapy. J Clin Pharm Ther 2000; 25: 197–220.

Wuttke

Rau

Heide

et al.

Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects. Clin Pharmacol Ther 2002; 72: 429–437.